ATAI Life Sciences NV (ATAI)
1.19
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
1.24
+0.05
(+4.20%)
After-Hours: 20:00
ATAI Life Sciences Shareholders Equity (Quarterly): 145.72M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Affimed NV | 19.21M |
| InflaRx NV | 72.91M |
| BioNTech SE | 21.35B |
| Immatics NV | 427.24M |
| CureVac NV | 809.41M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 197.52M |
| Total Liabilities (Quarterly) | 51.20M |
| Debt to Equity Ratio | 0.1561 |
| Current Ratio | 5.807 |
| Net Debt Paydown Yield | -0.77% |